Phase I and pharmacokinetic studies of topotecan administered as a 72 or 120 h continuous infusion.
about
A weekly regimen of cisplatin, paclitaxel and topotecan with granulocyte-colony stimulating factor support for patients with extensive disease small cell lung cancer: a phase II studyA phase I clinical and pharmacokinetic study of the new topoisomerase inhibitor GI147211 given as a 72-h continuous infusion.Topotecan-based combination chemotherapy in patients with transformed chronic myelogenous leukemia and advanced myelodysplastic syndromeTopoisomerase I inhibitors: the relevance of prolonged exposure for present clinical development.A phase I clinical trial of continual alternating etoposide and topotecan in refractory solid tumoursCancer therapies utilizing the camptothecins: a review of the in vivo literatureCurrent perspectives on camptothecins in cancer treatment
P2860
Q28364196-8CBF7888-F098-4C08-BC15-D0981BB34ED4Q33504409-A431B402-490A-4435-BBBD-0BCA18B6E241Q35937752-3E9FDC9C-247E-4833-A004-7532D05AC079Q36431807-F88D87A7-12B1-49EF-B4F6-1D73FCA183CDQ36614847-D191BA20-80BE-48CE-B047-AC7A231F1AD3Q37069556-E5EB4B22-66EE-416B-AC02-3C5ABF7BA20BQ42715927-89B2C75F-CED4-4D2A-880E-DF4D7DFF2D17
P2860
Phase I and pharmacokinetic studies of topotecan administered as a 72 or 120 h continuous infusion.
description
1994 nî lūn-bûn
@nan
1994 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
Phase I and pharmacokinetic st ...... or 120 h continuous infusion.
@ast
Phase I and pharmacokinetic st ...... or 120 h continuous infusion.
@en
type
label
Phase I and pharmacokinetic st ...... or 120 h continuous infusion.
@ast
Phase I and pharmacokinetic st ...... or 120 h continuous infusion.
@en
prefLabel
Phase I and pharmacokinetic st ...... or 120 h continuous infusion.
@ast
Phase I and pharmacokinetic st ...... or 120 h continuous infusion.
@en
P2093
P1433
P1476
Phase I and pharmacokinetic st ...... 2 or 120 h continuous infusion
@en
P2093
D A Rinaldi
D D Von Hoff
H A Burris
J R Eckardt
P304
P356
10.1097/00001813-199408000-00002
P577
1994-08-01T00:00:00Z